Diabetes mellitus and glaucoma

International Ophthalmology Clinics

Volumn 38, Issue 2, 1998, Pages 69-87

  Schertzer, Robert M ^a   Wang, Deliang ^a   Bartholomew, Luanna R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOSTEROID; FLUOROURACIL; MITOMYCIN C; NONSTEROID ANTIINFLAMMATORY AGENT;

CATARACTOGENESIS; CLOSED ANGLE GLAUCOMA; DIABETES MELLITUS; DISEASE SEVERITY; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER COAGULATION; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VISUAL FIELD;

EID: 0031844673     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199803820-00006     Document Type: Review

References (135)

1. Zeiter JH, Shin DH. Diabetes in primary open-angle glaucoma patients with inferior visual field defects. Graefes Arch Clin Exp Ophthalmol 1994;232(4):205-210
2. Garcia CA, Ruiz RS. Ocular complications of diabetes. Clin Symp 1992;44(1):2-32
3. Sanders RJ, Wilson MR. Diabetes-related eye disorders. J Natl Med Assoc 1993;85(2): 104-108
4. Tielsch JM, Katz J, Quigley HA, et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995;102(1):48-53
5. Frank RN. On the pathogenesis of diabetic retinopathy. A 1990 update. Ophthalmology 1991;98(5):586-593
6. Becker B. Diabetes mellitus and primary open-angle glaucoma: the XXVII Edward Jackson Memorial Lecture. Am J Ophthalmol 1971;71(1, pt 1):1-16
7. Armstrong JR, Daily RK, Dobson HL, et al. The incidence of glaucoma in diabetes mellitus: a comparison with the incidence of glaucoma in the general population. Am J Ophthalmol 1960;50(1):55-63
8. Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. Br Med J Clin Res Ed 1985;291(6488):93-95
9. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham eye study: II. Association of ophthalmic pathology with single variables previously measured in the Framingham heart study. Am J Epidemiol 1977;106(1):33-41
10. Dielemans I, de Jong PT, Stolk R, et al. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam study. Ophthalmology 1996;103(8):1271-1275
11. Mitchell P, Smith W, Chey T, et al. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997;104(4):712-718
12. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam eye study. Ophthalmology 1994;101(7):1173-1177
13. Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma. The Barbados eye study. Arch Ophthalmol 1995;113(7):918-924
14. Sprafka JM, Fritsche TL, Baker R, et al. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med 1990;150(4):857-861
15. Ponte F, Giuffre G, Giammanco R, et al. Risk factors of ocular hypertension and glaucoma. The Casteldaccia eye study. Doc Ophthalmol 1994;85(3):203-210
16. Leske MC, Podgor MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 1983;118(2):280-287
17. Klein BE, Klein R, Moss SE. Intraocular pressure in diabetic persons. Ophthalmology 1984;91(11):1356-1360
18. Katz J, Sommer A. Risk factors for primary open-angle glaucoma. Am J Prev Med 1988; 4(2):110-114
19. Reynolds DC. Relative risk factors for primary open-angle glaucoma: an epidemiological study. Am J Optom Physiol Opt 1977;54(2):116-120
20. Morgan RW, Drance SM. Chronic open-angle glaucoma and ocular hypertension: an epidemiological study. Br J Ophthalmol 1975;59(4):211-215
21. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983; 118(2):166-191
22. Jain IS, Luthra CL. Diabetic retinopathy: its relationship with intraocular pressure. Arch Ophthalmol 1967;78(2):198-200
23. Cristiansson J. Intraocular pressure in diabetes mellitus. Acta Ophthalmol 1961;39: 155-167
24. Ganley JP. Epidemiological aspects of ocular hypertension. Surv Ophthalmol 1980; 25(3):130-135
25. Bengtsson B. Aspects of epidemiology of chronic glaucoma. Acta Ophthalmol Suppl 1981;59(suppl 146):1-48
26. Armaly MF, Krueger DE, Maunder L, et al. Biostatistical analysis of collaborative glaucoma study: I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol 1980;98(12):2163-2171
27. Bouzas AG, Gragoudas ES, Balodimos MC, et al. Intraocular pressure in diabetes: relationship to retinopathy and blood glucose level. Arch Ophthalmol 1971;85(4):423-427
28. Seddon JM, Schwartz B, Flowerdew G. Case control study of ocular hypertension. Arch Ophthalmol 1983;101(6):891-894
29. Armaly MF, Baloglou PJ. Diabetes mellitus and the eye: II. Intraocular pressure and aqueous outflow facility. Arch Ophthalmol 1967;77(4):493-502
30. Konigsreuther KA, Jonas JB. Optic disc morphology in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 1995;233(4):200-204
31. Airaksinen PJ, Drance SM. Neuroretinal rim area and retinal nerve fiber-layer in glaucoma. Arch Ophthalmol 1985;103(2):203-204
32. Betz P, Camps F, Collignon-Brach J, et al. Biometric study of the disc cup in open-angle glaucoma. Graefs Arch Clin Exp Ophthalmol 1982;218(2):70-74
33. Caprioli J, Miller JM. Videographic measurements of optic nerve topography in glaucoma. Invest Ophthalmol Vis Sci 1988;29(8):1294-1298
34. Jonas JB, Nguyen XN, Naumann GOH. Parapapillary retinal vessel diameter in normal and glaucoma eyes: I. Morphometric data. Invest Ophthalmol Vis Sci 1989;30(7): 1599-1603
35. Jonas JB, Fernandez MC, Naumann GO. Glaucomatous parapapillary atrophy: occurrence and correlations. Arch Ophthalmol 1992;110(2):214-222
36. Quiglev HA, Addicks EM, Green WR, et al. Optic nerve damage in human glaucoma: II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99(4):635-649
37. Caprioli J, Miller JM. Optic disc rim area is related to disc size in normal subjects. Arch Ophthalmol 1987;105(12):1683-1685
38. Jonas JB, Gusek GC, Naumann GOH. Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes. Invest Ophthalmol Vis Sci 1988;29(7):1151-1158
39. Hong YS, Shin DH. Optic disc rim area is related to disc size in normal subjects. Arch Ophthalmol 1988;106(7):877-878
40. Airaksinen PJ, Drance SM, Schulzer M. Neuroretinal rim area in early glaucoma. Am J Ophthalmol 1985;99(1):1-4
41. Balazsi AG, Drance SM, Schulzer M, et al. Neuroretinal rim area in suspected glaucoma and early chronic open-angle glaucoma. Correlation with parameters of visual function. Arch Ophthalmol 1984;102(7):1011-1014
42. Klein BE, Moss SE, Klein R, et al. Neuroretinal rim area in diabetes mellitus. Invest Ophthalmol Vis Sci 1990;31(5):805-809
43. Powell HC, Myers RR, Costello ML. Endoneural fluid pressure (EFP) in galactose neuropathy. J Neuropathol Exp Neurol 1979;38:335
44. Gabbay KH, Snider JJ. Nerve conduction defect in galactose-fed rats. Diabetes 1972;21(5):295-300
45. Malmgren LT, Jakobsen J, Olsson Y. Permeability of blood-nerve barrier in galactose-fed rats. Exp Neurol 1979;66(3):758-770
46. Seneviratne KN. Permeability of blood nerve barriers in the diabetic rat. J Neurol Neurosurg Psychiatry 1972;35(2):156-162
47. Cahill GF Jr. Current concepts of diabetic complications with emphasis on heredity factors: a brief review. In: Sing CF, Skolnick M, eds. Genetic analysis of common diseases: applications to predictive factors in coronary disease. New York: Liss, 1979:113-125
48. Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985;92(9):1191-1196
49. Klein R, Klein BE, Moss SE, et al. Blood pressure and hypertension in diabetes. Am J Epidemiol 1985;122(1):75-89
50. Moore MV, Jeffcoate WJ, Haworth S. Autonomic neuropathy and the pathogenesis of glaucoma in diabetes mellitus. Diabet Med 1989;6(8):717-719
51. Clark CV, Mapstone R. Autonomic neuropathy in ocular hypertension. Lancet 1985;2(8448):185-187
52. Clark CV, Mapstone R. Systemic autonomic neuropathy in open-angle glaucoma. Doc Ophthalmol 1986;64(2):179-185
53. Hugkulstone CE, Smith LF, Vernon SA. Trabeculectomy in diabetic patients with glaucoma. Eye 1993;7(4):502-506
54. Levene RZ. Glaucoma filtering surgery factors that determine pressure control. Trans Am Ophthalmol Soc 1984;82:282-301
55. Hitchings RA, Grierson I. Clinico-pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983;103(1):84-88
56. Ferguson VM, Spalton DJ. Continued breakdown of the blood-aqueous barrier following cataract surgery. Br J Ophthalmol 1992;76(8):453-456
57. Cunliffe IA, Flanagan DW, Geroge ND, et al. Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br J Ophthalmol 1991;75(1):9-12
58. Oshika T, Kato S, Funatsu H. Quantitative assessment of aqueous flare intensity in diabetes. Graefes Arch Clin Exp Ophthalmol 1989;227(6):518-520
59. Sparrow JM, Neil HA, Bron AJ. Biometry and auto-fluorescence of the anterior ocular segment in diabetics with and without autonomic neuropathy: a case control study. Eye 1992;6(1):50-54
60. Clark CV, Mapstone R. Pupil cycle time in primary closed-angle glaucoma. Can J Ophthalmol 1986;21(3):88-91
61. Clark CV. Autonomic denervation hypersensitivity in the primary glaucomas. Eye 1989;3(3):349-354
62. Sparrow JM, Bron AJ, Brown NAP, et al. Biometry of the crystalline lens in early-onset diabetes. Br J Ophthalmol 1990;74(11):654-660
63. Michaelson IC. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1949;68:137-180
64. Ashton N. Retinal vascularization in health and disease: Proctor Award Lecture. Am J Ophthalmol 1957;44(4, pt 2):7
65. Sone H, Okuda Y, Kawakami Y, et al. Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated. Diabetes Care 1996;19(11):1306-1307
66. Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13(1):18-32
67. Adamis AP, Miller JW, Bernai MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118(4):445-450
68. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331(22):1480-1487
69. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266(18):11947-11954
70. Vlodavsky I, Folkman J, Sullivan R, et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987;84(8):2292-2296
71. Pepper MS, Ferrara N, Orci L, et al. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189(2):824-831
72. Muthukrishnan L, Warder E, McNeil PL. Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells. J Cell Physiol 1991;148(1):1-16
73. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion: III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90(5):488-506
74. Dueker DK. Neovascular glaucoma. In: Epstein DL, Allingham RR, Schuman JS, eds. Chandler & Grant's glaucoma, ed 4. Baltimore: Williams & Wilkins, 1997:309-318
75. Wand M, Dueker DK, Aiello LM, et al. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol 1978;86(3):332-339
76. Browning DJ. Risk of missing angle neovascularization by omitting screening gonioscopy in patients with diabetes mellitus. Am J Ophthalmol 1991;112(2):212
77. Blinder KJ, Friedman SM, Mames RN. Diabetic iris neovascularization. Am J Ophthalmol 1995;120(3):393-395
78. Bruun-Jensen J. Fluorescein angiography of the anterior segment. Am J Ophthalmol 1969;67(6):842-845
79. Fetkenhour CL, Choromokos E. Anterior segment fluorescein angiography with a retinal fundus camera. Arch Ophthalmol 1978;96(4):711-713
80. Ohnishi Y, Ishibashi T, Sagawa T. Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 1994;232(4):199-204
81. Jocson VL. Microvascular injection studies in rubeosis iridis and neovascular glaucoma. Am J Ophthalmol 1977;83(4):508-517
82. Teich SA, Walsh JB. A grading system for iris neovascularization: prognostic implications for treatment. Ophthalmology 1981;88(11):1102-1106
83. Krill AE, Archer D, Newell FW. Photocoagulation in complications secondary to branch vein occlusion. Arch Ophthalmol 1971;85(1):48-60
84. Callahan MA, Hilton GF. Photocoagulation and rubeosis iridis. Am J Ophthalmol 1974;78(5):873-874
85. Little HL, Rosenthal AR, Dellaporta A, et al. The effect of panretinal photocoagulation on rubeosis iridis. Am J Ophthalmol 1976;81(6):804-809
86. Laatikainen L, Kohner EM, Khoury D, et al. Panretinal photocoagulation in central retinal vein occlusion: a randomized controlled clinical study. Br J Ophthalmol 1977; 61(12):741-753
87. Murphy RP, Egbert PR. Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 1979;97(4):700-702
88. Tasman W, Magargal LE, Augsburger JJ. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 1980;87(5):400-402
89. Simmons RJ, Dueker DK, Kimbrough RL, et al. Goniophotocoagulation for neovascular glaucoma. Trans Am Acad Ophthalmol Otolaryngol 1977;83(1):80-89
90. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81(4):383-396
91. The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. Arch Ophthalmol 1979;97(4):654-655
92. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103(4):650-656
93. Molteno AC, Van Rooyen MM, Bartholomew RS. Implants for draining neovascular glaucoma. Br J Ophthalmol 1977;61(2):120-125
94. Krupin T, Kaufman P, Mandell A, et al. Filtering valve implant surgery for eyes with neovascular glaucoma. Am J Ophthalmol 1980;89(3):338-343
95. Schocket SS, Lakhanpal V, Richards RD. Anterior chamber tube shunt to an encircling band in the treatment of neovascular glaucoma. Ophthalmology 1982;89(10):1188-1194
96. Hersh SB, Kass MA. Iridectomy in rubeosis iridis. Ophthalmic Surg 1976;7(1):19-21
97. Herschler J, Agness D. A modified filtering operation for neovascular glaucoma Arch Ophthalmol 1979;97(12):2339-2341
98. Goldstein AL, Ide CH. Cyclocryotherapy for secondary glaucoma due to rubeosis iridis. Case reports. Mo Med 1972;69(9):736-739
99. Feibel RM, Bigger JF. Rubeosis iridis and neovascular glaucoma. Evaluation of cyclocryotherapy. Am J Ophthalmol 1972;74(5):862-867
100. Bellows AR, Grant WM. Cyclocryotherapy in advanced inadequately controlled glaucoma. Am J Ophthalmol 1973;75(4):679-684
101. Boniuk M. Cryotherapy in neovascular glaucoma. Trans Am Acad Ophthalmol Otolaryngol 1974;78(2):OP337-343
102. Krupin T, Mitchell KB, Becker B. Cyclocryotherapy in neovascular glaucoma. Am J Ophthalmol 1978;86(1):24-26
103. Drews RC. Corticosteroid management of hemorrhagic glaucoma. Trans Am Acad Ophthalmol Otolaryngol 1974;78(2):OP334-336
104. Chang EJ, Netland PA. Retrobulbar chlorpromazine for management of chronic pain in absolute glaucoma. Invest Ophthalmol Vis Sci 1996;37(3):S1100
105. Sadiq SA, Chatterjee A, Vernon SA. Progression of diabetic retinopathy and rubeotic glaucoma following cataract surgery. Eye 1995;9(6):728-738
106. Benson WE, Brown GC, Tasman W, et al. Extracapsular cataract extraction and placement of a posterior chamber lens in patients with diabetic retinopathy. Ophthalmology 1993;100(5):730-738
107. Jaffe GJ, Burton TC, Kuhn E, et al. Progression of nonproliferative retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992;114(4):448-456
108. Taylor E, Dobree JH. Proliferative diabetic retinopathy. Site and size of initial lesions. Br J Ophthalmol 1970;54(1):11-18
109. Wisznia KI, Lieberman TW, Leopold IH. Visual fields in diabetic retinopathy. Br J Ophthalmol 1971;55(3):183-188
110. Greite JH, Zumbansen HP, Adamczyk R. Visual field in diabetic retinopathy (DR). Greve EL, Verriest G, eds. In: Fourth International Visual Field Symposium 1980. Hague: W. Junk, 1981:25-32
111. Zeiter JH, Shin DH, Baek NH. Visual-field defects in diabetic patients with primary open-angle glaucoma. Am J Ophthalmol 1991;111(5):581-584
112. Aulhorn E, Harms H. Early visual-field defects in glaucoma. In: Leydhecker W, ed. Glaucoma: International Tutzing Symposium, (1966). Basel: S. Karger, 1967:151-186
113. Furuno F, Matsuo H. Early stage progression in glaucomatous visual-field changes. Doc Ophthalmol 1979;19:247-253
114. Hart WM, Becker B. The onset and evolution of glaucomatous visual field detects. Ophthalmology 1982;89(3):268-279
115. Heijl A, Lundqvist L. The frequency distribution of earliest glaucomatous visual-field defects documented by automatic perimetry. Acta Ophthalmol Copenh 1984;62(4):658-664
116. Harrington DO, Drake MV. Glaucoma. In: Harrington DO, Drake MV, eds. The visual fields: Text and atlas of clinical perimetry, ed. St Louis: Mosby, 1990:179-218
117. Heijl A. Strategies for detection of glaucoma defects. In: Drance SM, Anderson DR, eds. Automatic perimetry in glaucoma: a practical guide. New York: Grune & Stratton, 1985:43-54
118. Brenton RS, Phelps CD, Rojas P, et al. Interocular differences of the visual field in normal subjects. Invest Ophthalmol Vis Sci 1986;27(5):799-805
119. Henson DB, Dix SM, Oborne AC. Evaluation of the Friedman Visual-Field Analyser Mark II.:I. Results from a normal population. Br J Ophthalmol 1984;68(7):458-462
120. Brenton RS, Phelps CD. The normal visual field on the Humphrey Field Analyzer. Ophthalmologica 1986;193(1/2):56-74
121. Zalta AH. Lens rim artifact in automated threshold perimetry. Ophthalmology 1989;96(9):1302-1311
122. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol 1987;105(11):1544-1549
123. Aulhorn E. Visual field defects in chronic glaucoma. In: Heilman K, Richardson KT, eds. Glaucoma. Conceptions of a disease: pathogenesis, diagnosis, therapy. Philadelphia: Saunders, 1978:157-168
124. Katz J, Sommer A. Reliability indexes of automated perimetric tests. Arch Ophthalmol 1988;106(9):1252-1254
125. Nelson-Quigg JM, Twelker JD, Johnson CA. Response properties of normal observers and patients during automated perimetry. Arch Ophthalmol 1989;107(11):1612-1615
126. Johnson CA, Nelson-Quigg JM. Reliability of automated perimetric tests. Arch Ophthalmol 1990;108(6):777-778
127. Roth JA. Central visual field in diabetes. Br J Ophthalmol 1969;53(1):16-25
128. Trick GL, Trick LR, Kilo C. Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes. Ophthalmogy 1989;97(4):475-482
129. Dandona L, Quigley HA, Brown AE, et al. Quantitative regional structure of the normal human lamina cribrosa. A racial comparison. Arch Ophthalmol 1990;108(3):393-398
130. Ogasawara H, Feke GT, Yoshida A, et al. Altered optic nerve head circulation in Type I diabetes. Invest Ophthalmol Vis Sci 1990;31(suppl 4):137
131. Demick S, Ohnsman C, Hodges B, et al. Field defects in diabetic patients. Ophthalmology 1992;99(1):1-3
132. Lam BL, Alward WL, Kolder HE. Effect of cataract on automated perimetry. Ophthalmology 1991;98(7):1066-1070
133. Martin L. Cataract and high-pass resolution perimetry. Acta Ophthalmol Scand 1997; 75(2):174-177
134. Crichton A, Mikelberg F, Douglas GR, et al. Lens opacity as a predictor of visual field impairment due to cataract. Can J Ophthalmol 1990;25(6):287-289
135. House PH, Schulzer M, Drance SM, et al. The effect of lens opacity on the resolution visual field in normal subjects. Doc Ophthalmol 1993;83(1):27-32